Hereditary diffuse gastric cancer: A manifestation of lost cell polarity

Cancer Science

Volumn 100, Issue 7, 2009, Pages 1151-1157

  Humar, Bostjan ^a   Guilford, Parry ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; MATRIX METALLOPROTEINASE; UVOMORULIN; WNT PROTEIN;

CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL ADHESION; CELL FATE; CELL POLARITY; CLINICAL FEATURE; DNA METHYLATION; DOWN REGULATION; GENE MUTATION; GERM LINE; HEREDITARY DIFFUSE GASTRIC CANCER; HUMAN; MITOSIS INHIBITION; MITOSIS SPINDLE; NONHUMAN; ONCOGENE SRC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; TUMOR DIFFERENTIATION;

ANIMALS; CADHERINS; CARCINOMA, SIGNET RING CELL; CELL POLARITY; GASTRIC MUCOSA; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MODELS, BIOLOGICAL; STOMACH NEOPLASMS;

EID: 67449093573     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01163.x     Document Type: Review

References (67)

1. Chan JK, Wong CS. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast. Adv Anat Pathol 2001; 8: 165-72.
2. Berx G, Staes K, Hengel JV et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995; 26: 281-9.
3. Blair V, Martin I, Shaw D et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 2006; 4: 262-75.
4. Suriano G, Seixas S, Rocha J, Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med 2006; 84: 1023-31.
5. Corso G, Roviello F, Paredes J et al. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Eur J Surg Oncol 2007.
6. Humar B, Graziano F, Cascinu S et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002; 21: 8192-5.
7. Nasri S, More H, Graziano F et al. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population. BMC Cancer 2008; 8: 138.
8. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
9. Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG. Hereditary diffuse gastric cancer: Predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004; 53: 814-20.
10. Huntsman DG, Carneiro F, Lewis FR et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001; 344: 1904-9.
11. Humar B, Fukuzawa R, Blair V et al. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res 2007; 67: 2480-9.
12. Carneiro F, Huntsman DG, Smyrk TC et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004; 203: 681-7.
13. Humar B, Blair V, Charlton A, More H, Martin I, Guilford P. E-cadherin deficiency initiates gastric signet-ring cell neoplasia in mice and man. Cancer Res (in Press) 2009; 69: 2050-6.
14. Rogers WM, Dobo E, Norton JA et al. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): Pathologic findings with clinical implications. Am J Surg Pathol 2008; 32: 799-809.
15. Barber ME, Save V, Carneiro F et al. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol 2008; 216: 286-94.
16. Sunagawa M, Takeshita K, Nakajima A, Ochi K, Habu H, Endo M. Duration of ENNG administration and its effect on histological differentiation of experimental gastric cancer. Br J Cancer 1985; 52: 771-9.
17. Bleuming SA, He XC, Kodach LL et al. Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. Cancer Res 2007; 67: 8149-55.
18. Ward JM, Weisburger EK. Intestinal tumors in mice treated with a single injection of N-nitroso-N-butylurea. Cancer Res 1975; 35: 1938-43.
19. Hohenstein P, Molenaar L, Elsinga J et al. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene. Genes Chromosomes Cancer 2003; 36: 273-82.
20. More H, Humar B, Weber W et al. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 2007; 28: 203.
21. Schrader KA, Masciari S, Boyd N et al. Hereditary diffuse gastric cancer: Association with lobular breast cancer. Fam Cancer 2008; 7: 73-82.
22. Kaurah P, MacMillan A, Boyd N et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007; 297: 2360-72.
23. Grady WM, Willis J, Guilford PJ et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000; 26: 16-7.
24. Barber M, Murrell A, Ito Y et al. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol 2008; 216: 295-306.
25. Machado JC, Oliveira C, Carvalho R et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20: 1525-8.
26. Zou D, Yoon H-S, Perez D, Weeks R, Guilford P, Humar B. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia. J Pathol 2009 in press.
27. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nature Reviews 2007; 7: 415-28.
28. Hayashi M, Nimura K, Kashiwagi K et al. Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling. J Cell Sci 2007;120: 1350-7.
29. Cao Q, Yu J, Dhanasekaran SM et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008; 27: 7274-84.
30. Mutskov V, Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J 2004; 23: 138-49.
31. Clark SJ. Action at a distance: Epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 2007; 16 Spec No 1: R88-95.
32. Hahn MA, Hahn T, Lee DH et al. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res 2008; 68: 10 280-9.
33. Dumont N, Wilson MB, Crawford YG, Reynolds PA, Sigaroudinia M, Tlsty TD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 2008; 105: 14 867-72.
34. Hanby AM, Chinery R, Poulsom R, Playford RJ, Pignatelli M. Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am J Path 1996; 148: 723-9.
35. Demetter P, De Vos M, Van Damme N et al. Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. Am J Clin Pathol 2000; 114: 364-70.
36. Terres AM, Pajares JM, O'Toole D, Ahern S, Kelleher D. H. pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clin Pathol 1998; 51: 410-2.
37. Dohadwala M, Yang SC, Luo J et al. Cyclooxygenase-2-dependent regulation of E-cadherin: Prostaglandin E (2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res 2006; 66: 5338-45.
38. Krishnamachary B, Zagzag D, Nagasawa H et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006; 66: 2725-31.
39. Imai T, Horiuchi A, Wang C et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 2003; 163: 1437-47.
40. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: A meta-analysis. Am J Gastroenterol 2007; 102: 1789-98.
41. Karam SM, Straiton T, Hassan WM, Leblond CP. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells 2003; 21: 322-36.
42. Sugihara H, Hattori T, Fukuda M, Fujita S. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch a Pathol Anat Histopathol 1987; 411: 117-27.
43. Nejsum LN, Nelson WJ. A molecular mechanism directly linking E-cadherin adhesion to initiation of epithelial cell surface polarity. J Cell Biol 2007; 178: 323-35.
44. Drubin DG, Nelson WJ. Origins of cell polarity. Cell 1996; 84: 335-44.
45. Fleming ES, Zajac M, Moschenross DM et al. Planar spindle orientation and asymmetric cytokinesis in the mouse small intestine. J Histochem Cytochem 2007; 55: 1173-80.
46. Le Borgne R, Bellaiche Y, Schweisguth F. Drosophila E-cadherin regulates the orientation of asymmetric cell division in the sensory organ lineage. Curr Biol 2002; 12: 95-104.
47. Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 2005; 437: 275-80.
48. Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Res 2005; 65: 1783-91.
49. Eastham AM, Spencer H, Soncin F et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 2007; 67: 11 254-62.
50. Ramsey VG, Doherty JM, Chen CC, Stappenbeck TS, Konieczny SF, Mills JC. The maturation of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic cells requires Mist1. Development 2007; 134: 211-22.
51. Baba Y, Iyama K, Ikeda K et al. Differential expression of basement membrane type IV collagen alpha chains in gastric intramucosal neoplastic lesions. J Gastroenterol 2007; 42: 874-80.
52. Lu B, Roegiers F, Jan LY, Jan YN. Adherens junctions inhibit asymmetric division in the Drosophila epithelium. Nature 2001; 409: 522-5.
53. Januschke J, Gonzalez C. Drosophila asymmetric division, polarity and cancer. Oncogene 2008; 27: 6994-7002.
54. Wodarz A, Gonzalez C. Connecting cancer to the asymmetric division of stem cells. Cell 2006; 124: 1121-3.
55. Knoblich JA. Mechanisms of asymmetric stem cell division. Cell 2008; 132: 583-97.
56. Rasin MR, Gazula VR, Breunig JJ et al. Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci 2007; 10: 819-27.
57. Bredemeyer AJ, Geahlen JH, Weis VG et al. The gastric epithelial progenitor cell niche and differentiation of the zymogenic (chief) cell lineage. Dev Biol 2009; 325: 211-24.
58. Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-15.
59. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008; 3: E2888.
60. Barshishat M, Polak-Charcon S, Schwartz B. Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells. Br J Cancer 2000; 82: 195-203.
61. Milutinovic S, D'Alessio AC, Detich N, Szyf M. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 2007; 28: 560-71.
62. Tahara T, Shibata T, Nakamura M et al. Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci 2009.
63. Farnie G, Clarke RB. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Reviews 2007; 3: 169-75.
64. Liu S, Dontu G, Mantle ID et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006; 66: 6063-71.
65. Fukuda K, Yasugi S. The molecular mechanisms of stomach development in vertebrates. Dev Growth Differ 2005; 47: 375-82.
66. Li DW, Wu Q, Peng ZH, Yang ZR, Wang Y. [Expression and significance of Notch1 and PTEN in gastric cancer]. Chinese Journal of Cancer 2007; 26: 1183-7.
67. Yanai K, Nagai S, Wada J et al. Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J Surg Oncol 2007; 95: 55-62.